Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CRN help wanted

This article was originally published in The Tan Sheet

Executive Summary

The trade association has formed a committee to find a replacement for current President Annette Dickinson, PhD, who announced her tentative retirement after 31 years with CRN in June (1"The Tan Sheet" June 24, 2004, p. 14). Dickinson plans to retire in spring 2005, but could step down earlier if necessary "to accommodate a candidate who prefers to start sooner." The committee is comprised of nine CRN board members, including Natural Alternatives Chairman Mark LeDoux, Wyeth Consumer Healthcare Senior VP Andrew Davis, NBTY CFO Harvey Kamil, John Vernardos of Herbalife and Tom Zimmerman of Pharmavite...

You may also be interested in...



CRN’s Dickinson Concludes 31-Year Tenure

The Council for Responsible Nutrition will convene a search committee within the next few weeks to hire a successor for CRN President Annette Dickinson, PhD

Amneal’s Generics Business Reinvigorated By New Launches

As Amneal’s generics segment sees significant growth, the company has revealed plans to launch new products and expand in new markets. “We are extremely proud of the progress our company has made since we re-joined as leaders of Amneal,” said Chirag and Chintu Patel, co-CEOs of Amneal.

Medtech SMEs See Opportunities In UK Budget Of Few Surprises

Schemes and funding to support growth in the life sciences and medtech sectors featured in the UK government’s spring budget on 3 March.

Topics

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel